Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MANOHAR L JETHANI

Allopathic & Osteopathic Physicians Family Medicine

NPI
1366529505
CMS profile
16327
Location
BERWYN, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$9,264.52

181 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 3 of 4; records 101–150 of 181 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MANOHAR L JETHANI

NPI 1366529505 · CMS profile ID 16327

Allopathic & Osteopathic Physicians / Family Medicine

BERWYN, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 181 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1366529505?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MANOHAR L JETHANI, NPI 1366529505, CMS profile ID 16327. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 181 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1366529505?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). MANOHAR L JETHANI, NPI 1366529505, CMS profile ID 16327. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 181 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1366529505?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
MANOHAR L JETHANI, NPI 1366529505, CMS profile ID 16327, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 181 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1366529505?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

181 matching records · $9,264.52 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 181 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 181.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Pharmaceuticals, Inc $7.9405/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788159717 CMS
Amarin Pharma Inc. $17.2005/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815421039 CMS
Currax Pharmaceuticals LLC $13.7805/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792531237 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.7005/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850225195 CMS
AbbVie Inc. $5.7105/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794966069 CMS
Esperion Therapeutics, Inc. $24.7105/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838320579 CMS
Novo Nordisk Inc $4.2005/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811722847 CMS
Amgen Inc. $124.4105/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825572441 CMS
Novartis Pharmaceuticals Corporation $24.1205/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812733761 CMS
Amgen Inc. $13.0005/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826385019 CMS
Novartis Pharmaceuticals Corporation $15.6205/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812733759 CMS
Amgen Inc. $121.8105/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825572429 CMS
Regeneron Healthcare Solutions, Inc. $28.4605/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809589989 CMS
AstraZeneca Pharmaceuticals LP $87.5005/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829555343 CMS
SANOFI-AVENTIS U.S. LLC $18.3705/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843450053 CMS
AbbVie Inc. $3.2705/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794966061 CMS
AbbVie Inc. $15.8705/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794966065 CMS
ARBOR PHARMACEUTICALS, INC. $16.6004/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830939871 CMS
Allergan, Inc. $17.3204/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792821179 CMS
AbbVie Inc. $23.4704/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794966057 CMS
Novo Nordisk Inc $8.1004/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811203465 CMS
Amgen Inc. $17.3504/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825572413 CMS
AbbVie Inc. $8.5304/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794966055 CMS
SANOFI-AVENTIS U.S. LLC $15.0204/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843450061 CMS
Novo Nordisk Inc $18.5704/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810679365 CMS
Esperion Therapeutics, Inc. $21.7504/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838320575 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $12.4504/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850275473 CMS
Amgen Inc. $27.5504/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826385015 CMS
Janssen Pharmaceuticals, Inc $8.9904/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788159713 CMS
Lilly USA, LLC $16.1004/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818639435 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.1904/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763702042 CMS
Esperion Therapeutics, Inc. $125.0004/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838320571 CMS
Esperion Therapeutics, Inc. $1,100.0004/13/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838320567 CMS
Currax Pharmaceuticals LLC $16.5104/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792531235 CMS
AbbVie Inc. $13.8304/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794966051 CMS
Esperion Therapeutics, Inc. $275.0004/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838320561 CMS
Esperion Therapeutics, Inc. $1,410.0004/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838320565 CMS
Amarin Pharma Inc. $12.5204/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815164647 CMS
Kowa Pharmaceuticals America, Inc. $28.6704/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 805498985 CMS
Smith+Nephew, Inc. $33.0404/02/2021 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 843210625 CMS
AbbVie Inc. $7.5004/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794966047 CMS
Currax Pharmaceuticals LLC $11.6403/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792531233 CMS
Esperion Therapeutics, Inc. $1,700.0003/31/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838320557 CMS
Novo Nordisk Inc $17.8303/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810679361 CMS
Mylan Specialty L.P. $18.7003/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965407723 CMS
Esperion Therapeutics, Inc. $118.1003/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838320553 CMS
Horizon Therapeutics plc $22.6703/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797153559 CMS
Esperion Therapeutics, Inc. $21.7503/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838320551 CMS
Lilly USA, LLC $20.8303/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818606881 CMS
Smith+Nephew, Inc. $15.5103/17/2021 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 842964991 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $16,911.65 122
PY2020 $8,653.47 125
PY2021 $9,264.52 181
PY2022 $3,359.76 130
PY2023 $5,021.15 126
PY2024 $3,385.85 144
PY2025 $3,241.69 89

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $645,769.32 50
PY2024 Recipient $2,787.11 7
PY2024 Principal investigator $659,798.36 30
PY2023 Principal investigator $1,923,742.68 151
PY2022 Principal investigator $1,136,935.12 101
PY2021 Principal investigator $428,149.50 25
PY2020 Principal investigator $20,241.50 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

50 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Ionis Pharmaceuticals, Inc. $452.64 12/03/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246791001
Principal investigator 1 SANOFI PASTEUR INC. $17,208.80 11/21/2025 Non-covered Recipient Entity
Alliance For Multispecialty Research Llc
A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older No dispute reported 06/30/2026 1226107387
Principal investigator 1 ModernaTX, Inc. $10,657.90 11/19/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALITY RESEARCH, LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965309
Principal investigator 1 Ionis Pharmaceuticals, Inc. $2,386.48 11/04/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246790040
Principal investigator 1 SANOFI PASTEUR INC. $22,125.60 10/23/2025 Non-covered Recipient Entity
Alliance For Multispecialty Research Llc
A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older No dispute reported 06/30/2026 1226107491
Principal investigator 1 ModernaTX, Inc. $5,936.60 10/22/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALITY RESEARCH, LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965291
Principal investigator 1 Ionis Pharmaceuticals, Inc. $500.00 10/08/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS9 No dispute reported 06/30/2026 1246788112
Principal investigator 1 Ionis Pharmaceuticals, Inc. $575.00 10/08/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS9 No dispute reported 06/30/2026 1246788116
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,725.00 10/08/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS9 No dispute reported 06/30/2026 1246788119
Principal investigator 1 Ionis Pharmaceuticals, Inc. $3,740.00 10/08/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS9 No dispute reported 06/30/2026 1246788123
Principal investigator 1 Ionis Pharmaceuticals, Inc. $26,181.71 10/08/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS9 No dispute reported 06/30/2026 1246788126
Principal investigator 1 Ionis Pharmaceuticals, Inc. $905.28 10/03/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246787899
Principal investigator 1 ModernaTX, Inc. $7,955.85 09/17/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965301
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,857.48 08/29/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786962
Principal investigator 1 ModernaTX, Inc. $12,814.77 08/15/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965295
Principal investigator 1 Ionis Pharmaceuticals, Inc. $7,620.41 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786117
Principal investigator 1 Ionis Pharmaceuticals, Inc. $452.97 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786163
Principal investigator 1 Ionis Pharmaceuticals, Inc. $5,548.00 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786199
Principal investigator 1 Ionis Pharmaceuticals, Inc. $4,467.76 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786237
Principal investigator 1 Ionis Pharmaceuticals, Inc. $2,173.18 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786272
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,267.22 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786280
Principal investigator 1 Ionis Pharmaceuticals, Inc. $4,173.90 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786286
Principal investigator 1 Ionis Pharmaceuticals, Inc. $3,668.70 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786290
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,589.04 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786311
Principal investigator 1 Ionis Pharmaceuticals, Inc. $3,317.75 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786314
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,607.25 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786319
Principal investigator 1 Ionis Pharmaceuticals, Inc. $2,365.05 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS15 No dispute reported 06/30/2026 1246786323
Principal investigator 1 ModernaTX, Inc. $22,685.85 08/01/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ?60 Years of Age No dispute reported 06/30/2026 1252965297
Principal investigator 1 ModernaTX, Inc. $37,581.20 08/01/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ?60 Years of Age No dispute reported 06/30/2026 1252965313
Principal investigator 1 ModernaTX, Inc. $1,321.60 08/01/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ?60 Years of Age No dispute reported 06/30/2026 1252965315
Principal investigator 1 ModernaTX, Inc. $4,234.92 07/18/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965321
Principal investigator 1 Amgen Inc. $4,602.36 07/10/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity No dispute reported 06/30/2026 1246639067
Principal investigator 1 Ionis Pharmaceuticals, Inc. $5,786.35 07/10/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS9 No dispute reported 06/30/2026 1246785162
Principal investigator 1 ModernaTX, Inc. $8,077.00 06/18/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965307
Principal investigator 1 SANOFI PASTEUR INC. $19,005.00 06/13/2025 Non-covered Recipient Entity
Alliance For Multispecialty Research,llc
A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older No dispute reported 06/30/2026 1226113098
Principal investigator 1 Lexicon Pharmaceuticals, Inc. $861.00 05/21/2025 Non-covered Recipient Entity
RESEARCH NETWORK AMERICA
LX9211.1-204-DPN No dispute reported 06/30/2026 1248066411
Principal investigator 1 Lexicon Pharmaceuticals, Inc. $4,100.00 05/21/2025 Non-covered Recipient Entity
RESEARCH NETWORK AMERICA
LX9211.1-204-DPN No dispute reported 06/30/2026 1248066413
Principal investigator 1 ModernaTX, Inc. $16,318.99 05/21/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965293
Principal investigator 1 SANOFI PASTEUR INC. $55,730.24 05/16/2025 Non-covered Recipient Entity
Alliance For Multispecialty Research,llc
A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older No dispute reported 06/30/2026 1226113716
Principal investigator 1 ModernaTX, Inc. $8,807.70 05/07/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965305
Principal investigator 1 SANOFI PASTEUR INC. $189,879.16 04/28/2025 Non-covered Recipient Entity
Alliance For Multispecialty Research,llc
A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older No dispute reported 06/30/2026 1226113820
Principal investigator 1 SANOFI PASTEUR INC. $15,767.00 04/09/2025 Non-covered Recipient Entity
Alliance For Multispecialty Research,llc
A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older No dispute reported 06/30/2026 1226113662
Principal investigator 1 ModernaTX, Inc. $16,509.66 03/19/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965319
Principal investigator 1 ModernaTX, Inc. $3,105.00 02/26/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ?60 Years of Age No dispute reported 06/30/2026 1252965311
Principal investigator 1 ModernaTX, Inc. $196.43 02/21/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965303
Principal investigator 1 ModernaTX, Inc. $10,795.52 02/19/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965317
Principal investigator 1 ModernaTX, Inc. $1,500.00 02/12/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965323
Principal investigator 1 ModernaTX, Inc. $19,693.34 01/24/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252965299
Principal investigator 1 AstraZeneca Pharmaceuticals LP $20,200.00 01/15/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH
a phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like particle VLP vaccine in adults 60 years of age and older No dispute reported 06/30/2026 1185548527
Principal investigator 1 Novartis Pharmaceuticals Corporation $25,736.66 01/14/2025 Non-covered Recipient Entity
AFFINITY HEALTH CORP
A randomized, parallel-group, 24 week, double-blind, placebo-controlled, multicenter Phase 3 study to assess the efficacy and safety of secukinumab compared to placebo in adult patients with active rotator cuff tendinopathy No dispute reported 06/30/2026 1190310783